Apr 19, 2023
Vidyadhara et al., 2023 “Dopamine transporter…Parkinson’s Disease" (L-DOPA treatment, IHC, HPLC, Microscopy Imaging and Analysis, Western Blotting, and FSCV)
- 1Department of Neurology, Yale School of Medicine;
- 2Aligning Science Across Parkinson’s
Protocol Citation: Vidyadhara DJ 2023. Vidyadhara et al., 2023 “Dopamine transporter…Parkinson’s Disease" (L-DOPA treatment, IHC, HPLC, Microscopy Imaging and Analysis, Western Blotting, and FSCV). protocols.io https://dx.doi.org/10.17504/protocols.io.ewov1obeolr2/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 05, 2023
Last Modified: May 31, 2024
Protocol Integer ID: 80045
Keywords: L-DOPA treatment, Immunohistochemistry, HPLC, electron microscopy tissue preparation and settings, Surgery and in vivo Fast Scanning Cyclic Voltammetry, Western blotting, ASAPCRN
Funders Acknowledgement:
Aligning Science Across Parkinson’s
Grant ID: ASAP-000529
Abstract
This protocol details L-DOPA treatment, Immunohistochemistry, HPLC, and electron microscopy tissue preparation and settings and FSCV in publication "Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease."
Attachments
695-1480.docx
30KB
Materials
Reagents:
- 0.9% saline with 0.1 % heparin (50 µg of heparin in 1 ml distilled water)
- 2% EM grade paraformaldehyde (PFA) and 2% glutaraldehyde, prepared in 0.1M PB (prepared from 16% EM grade PFA, EMS sciences, catalog no.: 15710)
- 2.5% glutaraldehyde + 2% PFA + 0.1 M cacodylate buffer (borrow from EM facility)
- 0.1 M cacodylate buffer
ParaformaldehydeElectron Microscopy SciencesCatalog #15710
Buffers:
2X Sample Buffer (50 mL stock consisting of):
| A | B | |
| 0.5 M Tris (pH 6.8) | 12.5 mL (Final conc. of 125 mM) | |
| 10% SDS | 20 mL (Final conc. of 4%) | |
| 20% glycerol | 10 mL | |
| Dithiothreitol (DTT, 100 mM) | 0.77 g | |
| Bromophenol blue (0.33 mg/mL) | 16.5 mg | |
| H2O | 7.5 mL |
5X Sample Buffer (100 mL stock consisting of):
| A | B | |
| Tris pH 6.8, 1.0 M | 31.25 mL (final conc. 312.5 mM) | |
| SDS | 10 g (final conc. 10%) | |
| Glycerol | 50 mL (final conc. 50%) | |
| DTT (Mr 154.2) | 3.855 g (final conc. 250 mM) | |
| Bromophenol Blue | 50 mg, leading to 0.5 mg/ml (0.05%) | |
| H2O | to add up to 100 mL final volume |
Filter using 0.2 µm syringe filter after preparation.
Aliquot in 10 mL and store at -20°C.
1.5M Tris (pH 8.8) - total 500 mL
90.86 g Tris
Adjust pH to 8.8 with HCl
Filter
0.5M Tris (pH 6.8) - total 500 mL
30.29 g Tris
Adjust pH to 6.8 with HCl
Filter
10X tank buffer (running buffer) - total 6 L
| A | B | |
| Tris | 180 g | |
| Glycine | 864 g | |
| SDS (add last) | 60 g |
To get 1X that contains 0.025M Tris, 0.192M Glycine, 0.1% SDS.
10x transfer buffer - total 1 L
| A | B | |
| Tris | 30 g | |
| Glycine | 144 g |
2 L transfer buffer (for one transfer tank (4 gels))
| A | B | |
| Transfer buffer | 200 mL | |
| Methanol | 400 mL | |
| DW | 1400 mL |
10x TBS-T - total 2 L
| A | B | |
| Tris | 24.2 g | |
| NaCl | 174 g | |
| pH with HCl to 8.0 | 11 mL | |
| Tween-20 | 10 mL |
To get 1X containing 10 mM Tris, 150 mM NaCl, and 0.05% Tween-20.
Blocking Buffer
- 5% nonfat dry Milk
- 5% Goat serum in TBST
L-DOPA treatment
L-DOPA treatment
Prepare the L-DOPA treatment solution by dissolving L-DOPA powder in 0.85% saline solution to achieve a concentration of 15 mg/kg body weight.
Select adult mice for the study and divide them into pre-treatment and post-treatment groups.
Conduct behavior testing on the pre-treatment group one week before the L-DOPA treatment to establish a baseline for comparison.
On the day of the experiment, inject each mouse in the post-treatment group with a single dose of the L-DOPA treatment solution through the intraperitoneal route, at a dosage of 15 mg/kg body weight and volume of 10 ml/kg body weight.
Conduct behavior testing on the post-treatment group 20-25 minutes after the L-DOPA treatment to measure the effect of the treatment.
Use the pre-treatment group as a control to compare the behavioral differences before and after L-DOPA treatment.
Immunohistochemistry
Immunohistochemistry
Anesthetize the mice using isoflurane inhalation and perfuse intracardially with 0.9% heparinized saline followed by chilled 4% paraformaldehyde (PFA) in 0.1 Molarity (M) phosphate buffer (PB).
Post-fix the brains in the same buffer for 48:00:00 .
2d
Cryoprotect the brains in increasing grades of buffered sucrose (15 and 30%, prepared in 0.1 Molarity (M) PB), at 4 °C .
Store the brains at -80 °C until sectioning.
Perform serial sections of the brains (30 µm thick) coronally using a cryostat (Leica CM1850, Germany).
Collect the sections on gelatinized slides and store them at -20 °C .
Immunohistochemistry: Immunoperoxidase staining
Immunohistochemistry: Immunoperoxidase staining
For immunoperoxidase staining, perform endogenous peroxidase quenching using 0.1% H2O2 in 70% methanol (00:30:00 ).
30m
Block with 3% bovine serum albumin (BSA) (02:00:00 ) at Room temperature . Incubate sections at 4 °C with primary antibody (02:00:00 at Room temperature , then Overnight ).
6h
Incubate sections with biotin-conjugated secondary antibody at Room temperature (1:200; 3-4 hours, Vector Laboratories, PK-6101). Perform tertiary labeling with the avidin-biotin complex solution at Room temperature (1:100; 3-4 hours, Vector Laboratories, PK-6101).
Visualize staining using 3,3′-diaminobenzidine (Fluka, 32750) as a chromogen in a solution of 0.1 Molarity (M) acetate imidazole buffer (7.4 ) and H2O2 (0.1%).
Immunohistochemistry: Immunofluorescence staining
Immunohistochemistry: Immunofluorescence staining
Equilibration: Rinse the sample with 0.01 Molarity (M) PBS for 00:05:00 , followed by rinsing with 0.01 Molarity (M) PBS + 0.1% Tx for another 00:05:00 .
10m
Penetration: Apply 0.01 Molarity (M) PBS + 0.5% Tx for 10-20 minutes (start with 15 minutes and adjust as needed), then wash 3 times.
Neutralization: Incubate with 0.3 Molarity (M) Glycine in 0.01 Molarity (M) PBS (without Tx) for 00:20:00 , then wash 3 times.
20m
Blocking: Incubate with 3% goat serum (GS) in working/wash buffer for 1.5 to 2 hours. Wash 2-3 times gently.
Primary incubation: Dilute the required concentration of primary antibody in 1% GS in working/wash buffer. Incubate for 02:00:00 at Room temperature and Overnight at 4 °C . Wash 3-4 times.
4h
Secondary incubation: Dilute the secondary antibody in 1% GS in working/wash buffer at a 1:500 ratio. Incubate for 2-3 hours at Room temperature . Wash 3-4 times with working/wash buffer and 2 more times with 0.01 Molarity (M) PBS (without Tx).
Mount with DAPI.
Use 1X PBS with 0.1% Triton-X-100 as both washing and working buffer for both immunoperoxidase and immunofluorescence staining, except for phospho-antibodies where 1X Tris buffer saline can be used.
High-performance liquid chromatography (HPLC)
High-performance liquid chromatography (HPLC)
Anesthetize mice using isoflurane inhalation and sacrifice them by cervical dislocation.
Quickly remove and dissect the brains for dorsal striatum and snap freeze them. Store the tissues at -80 °C until further use.
Homogenize the tissues using a handheld sonic tissue dismembrator in 100-750 µL of 0.1 Molarity (M) TCA containing 0.01 Molarity (M) sodium acetate, 0.1 millimolar (mM) EDTA, and 10.5% methanol (3.8 ).
Spin the homogenates in a microcentrifuge at 10000 x g, 00:20:00 and collect the supernatant for HPLC-ECD analysis.
20m
Estimate protein concentration using Pierce™ BCA Protein Assay Kit (Thermo Scientific).
Use the same buffer used for tissue homogenization as the HPLC mobile phase.
Perform HPLC using a Kinetix 2.6um C18 column (4.6 x 100 mm, Phenomenex, Torrance, CA USA).
Unbiased stereology to count midbrain dopaminergic neurons
Unbiased stereology to count midbrain dopaminergic neurons
Use the optical fractionator probe of the StereoInvestigator (Software Version 8.1, Micro-brightfield Inc., Colchester, USA) connected to a brightfield microscope to perform stereological quantification of tyrosine hydroxylase (TH) positive dopaminergic neurons.
Delineate the substantia nigra pars compacta (SNpc) and ventral tegmental area (VTA) on every 6th TH+ve midbrain section using a 10X objective.
Identify the mounted thickness as 22.5 µm , which is also determined at every fifth counting site.
Imply a guard zone of 3.5 µm on either side, thus providing 15 µm of z-dimension to the optical dissector.
Count the neurons using a 40X objective with a regular grid interval of 22,500 μm² (x=150 μm, y=150 μm) and a counting frame size of 3600 μm² (x=60 μm, y=60 μm).
Begin the quantification at the first anterior appearance of TH+ve neurons in the midbrain structures to the caudal most part in each hemisphere separately, which is later summed to derive total numbers.
Electron Microscopy Tissue Preparation and Settings
Electron Microscopy Tissue Preparation and Settings
Make sure that both freshly prepared saline and fixatives (2% PFA + 2% GA) are chilled.
Anesthetize the mouse with isoflurane inhalation in a desiccator.
Perform intracardial perfusion with chilled 0.9% heparinized saline for ~15-20 minutes (until the fluid that comes out of the heart become colorless) at a flow rate of 2 mL /minute.
Change the perfusion solution to a fixative, (2% PFA + 2% GA) (chilled) and flush it for 20-25 minutes (until tail, head and neck are stiff) at a flow rate of 2 mL /minute.
After intracardial perfusion, remove the whole brain from the skull and immerse in 2.5% glutaraldehyde + 2% PFA + 0.1 Molarity (M) cacodylate buffer, 02:00:00 at Room temperature , followed by Overnight incubation at 4 °C (immersion fixation).
4h
Next day, perform vibratome sectioning (200 µm thick) of your area of interest*, using chilled 0.1 Molarity (M) PBS (in the vibratome trough).
Immediately after sectioning, transfer the 200 µm thick sections back to 2.5% glutaraldehyde + 2% PFA + 0.1 Molarity (M) cacodylate buffer and allow it equilibrate for ~00:30:00 at 4 °C .
30m
Wash the sections.
Wash the sections in 0.1 Molarity (M) cacodylate buffer for 00:02:00 . (1/3)
2m
Wash the sections in 0.1 Molarity (M) cacodylate buffer for 00:02:00 . (2/3)
2m
Wash the sections in 0.1 Molarity (M) cacodylate buffer for 00:02:00 . (3/3)
2m
Then, place the sections in the same buffer and deliver them to EM core for further processing.
EM imaging can be performed using FEI Tecnai G2 Spirit BioTwin Microscope.
Images are analysed using either FIJI (NIH) or iTEM software (ResAlta Research Technologies, USA).
Confocal/Fluorescence Microscopy and Image Analysis
Confocal/Fluorescence Microscopy and Image Analysis
Acquire fluorescent images using a laser scanning confocal microscope (LSM 800, Zeiss) with a 20X or 40X or 63X objectives or using a fluorescence slide scanner (VS200, Olympus) at 40X objective.
Ensure appropriate Z-depth is used.
Blind all images for genotype and age before subjecting to analysis using FIJI software from National Institute of Health (NIH).
After performing sum intensity projection, measure the expression intensity on an 8-bit or 16-bit image as the mean gray value on a scale of 0-255 or 0-65536, respectively.
To count microglial cells, threshold images using the ‘otsu’ algorithm and count cells larger than 75-pixel units for a given image using the ‘analyze particles' function.
To count immunofluorescence labeled dopaminergic neurons, use a similar method with a size threshold of 25 µm2 and above.
Count astroglial cells manually using the ‘cell counter’ function.
To count abnormal structures in the terminals, threshold images using the ‘triangle’ algorithm, followed by ‘analyse particles’ function. Count all the structures of size 5 µ2 and above and the circularity between 0.3 to 1.
Count autophagic punctae manually using the ‘cell counter’ function, which can be further validated on thresholded images using ‘triangle’ algorithm, followed by ‘analyse particles’ function (size: 0.5 µ2, circularity: 0.0 to 1).
Perform colocalization analysis using the “Coloc 2” function.
Western blotting
Western blotting
Homogenize the samples using an appropriate buffer and determine their protein concentration using a protein assay (such as the Bradford or BCA assay). Adjust the protein concentration of the samples to the desired amount using the buffer.
Heat the samples at 95 °C for 00:10:00 if fresh, or 5 minutes if previously heated, to denature the proteins.
10m
Load precast or poured polyacrylamide gels with the desired concentration and number of wells. Ensure that the gel is completely polymerized before loading the samples.
Run the gels at 65 V through the stacking gel for about 30-45 minutes until the dye front reaches the top of the stacking gel. Then, increase the voltage to 120 V and run until the dye front reaches the bottom of the resolving gel or runs off the gel.
Incubate the PVDF membrane in 100% methanol for 00:01:00 on a shaker to activate the membrane. Discard the methanol and rinse the membrane with distilled water.
1m
Incubate the activated membrane in distilled water for 00:01:00 on a shaker to rehydrate the membrane.
1m
Soak the membrane in transfer buffer for 10-15 minutes prior to use to equilibrate the membrane with the buffer.
Assemble the transfer sandwich by placing the gel on top of the anode (black side), followed by a sponge soaked in transfer buffer, a piece of transfer paper, the PVDF membrane, another piece of transfer paper, a sponge soaked in transfer buffer, and finally the cathode (white side).
Note
Make sure the white side of the cassette is oriented towards the red electrode so the current passes through the gel to the membrane.
Transfer the proteins from the gel to the membrane by running the transfer at 4 °C at constant 400 mAmps for 04:00:00 (Overnight ) or at constant 100 V for 01:00:00 , depending on the properties of the protein of interest.
6h
After transfer, incubate the blots in 6 mL of blocking solution (such as 1X TBS + 5% non-fat milk + 5% goat serum) for 01:00:00 at Room temperature on a rocker to block nonspecific binding sites.
1h
Incubate the blots Overnight on a rocker at 4 °C in the primary antibody diluted in 1X TBS + 5% non-fat milk + 5% goat serum.
Note
Optional: Add 5 µL of 10% SDS to the primary antibody solution.
1h
Wash the blots with 1X TBST (TBS + 0.1% Tween-20) to remove unbound primary antibody.
Wash the blots for 00:05:00 with 1X TBST. (1/3)
5m
Wash the blots for 00:05:00 with 1X TBST. (2/3)
5m
Wash the blots for 00:05:00 with 1X TBST. (3/3)
5m
Incubate the blots for 01:00:00 at Room temperature on a rocker in the secondary antibody diluted in 1X TBST + 5% non-fat milk + 5% goat serum (optional: add 5 µL of 10% SDS to the secondary antibody solution).
1h
Wash the blots 3 times for 5 minutes each with 1X TBST to remove unbound secondary antibody.
Wash the blots for 00:05:00 each with 1X TBST. (1/3)
5m
Wash the blots for 00:05:00 each with 1X TBST. (2/3)
5m
Wash the blots for 00:05:00 each with 1X TBST. (3/3)
5m
Rinse the blots with TBS to remove residual Tween-20.
Image the blots using an appropriate detection method (such as chemiluminescence or fluorescence) and a suitable imaging system. Store the blots in TBS buffer or dry them and store them between filter papers in a light-protected bag.
Surgery and in vivo Fast Scanning Cyclic Voltammetry (FSCV)
Surgery and in vivo Fast Scanning Cyclic Voltammetry (FSCV)
Anesthetize mice using isoflurane (SomnoSuite Small Animal Anesthesia System, Kent Scientific; induction 2.5%, maintenance 0.8–1.4% in O2, 0.35 l/min).
Fix the head of the mouse on a stereotaxic frame (Kopf Instruments, Tujunga, CA).
Apply Puralube vet ointment on the eye to prevent cornea from drying out.
Use a stereotactic drill (0.8 mm) to perform a craniotomy (unilateral, right) to target the midbrain and dorsal striatum with the following coordinates (values are in mm from Bregma):
Midbrain: anteroposterior = -2.9, mediolateral=+1.0, dorsoventral=+4
Dorsal Striatum: anteroposterior = +1.2, mediolateral = +1.3, dorsoventral = +3.1
Place an Ag/AgCl reference electrode via a saline bridge under the skin.
Lower a 22G bipolar stimulating electrode (P1 Technologies, VA, USA) to target ventral midbrain (between 4-4.5mm). Adjust the exact depth for maximal dopamine release.
Lower a custom-built carbon fiber electrode (5 μm diameter, cut to ∼150 μm length, Hexcel Corporation, CT, USA) to reach dorsal striatum for recording the evoked dopamine release.
Use dil-coated carbon-fiber electrodes to identify the electrode position in the dorsal striatum and the electrode track in the brain tissue to identify the position of the stimulation electrode.
Measure the evoked dopamine release using constant current (400μA), delivered using an Iso-Flex stimulus isolator triggered by a Master-9 pulse generator (AMPI, Jerusalem, Israel). A single burst stimulation consists of 30 pulses at 50Hz (0.6s).
Calibrate electrodes using a known concentration of dopamine in artificial cerebrospinal fluid (ACSF).
Use IGOR Pro for the data acquisition and analysis.
Note
Acquire code here: https://doi.org/10.1073/pnas.2013652117.
Protocol references
IGOR Pro: https://doi.org/10.1073/pnas.2013652117.